PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA

Nasopharyngeal carcinoma is a rare tumor that accounts for 1-3% of all childhood malignancies. A 16-year-old patient with refractory nasopharyngeal carcinoma, whose treatment has to be interrupted due to COVID-19 positivity.After 6 weeks because of disease progression, we started his chemotherapy al...

Descripción completa

Detalles Bibliográficos
Autores principales: Şahin, Seda, Sarı, Neriman, Özyörük, Derya, Özdemir, Sonay İncesoy, Gülhan, Belgin, İlhan, İnci Ergürhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Editora Ltda. 2021
Materias:
RARE TUMOURS AND HISTIOCYTOSIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572567/
http://dx.doi.org/10.1016/j.htct.2021.10.1007
_version_ 1784595239437074432
author Şahin, Seda
Sarı, Neriman
Özyörük, Derya
Özdemir, Sonay İncesoy
Gülhan, Belgin
İlhan, İnci Ergürhan
author_facet Şahin, Seda
Sarı, Neriman
Özyörük, Derya
Özdemir, Sonay İncesoy
Gülhan, Belgin
İlhan, İnci Ergürhan
author_sort Şahin, Seda
collection PubMed
description Nasopharyngeal carcinoma is a rare tumor that accounts for 1-3% of all childhood malignancies. A 16-year-old patient with refractory nasopharyngeal carcinoma, whose treatment has to be interrupted due to COVID-19 positivity.After 6 weeks because of disease progression, we started his chemotherapy altough he is still COVID-19 positive. We didn't see any complication. Prolonged COVID-19 positivity is thought to be associated with the infection of immortal malignant cells located in the nasopharynx
format Online
Article
Text
id pubmed-8572567
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Editora Ltda.
record_format MEDLINE/PubMed
spelling pubmed-85725672021-11-08 PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA Şahin, Seda Sarı, Neriman Özyörük, Derya Özdemir, Sonay İncesoy Gülhan, Belgin İlhan, İnci Ergürhan Hematol Transfus Cell Ther RARE TUMOURS AND HISTIOCYTOSIS Nasopharyngeal carcinoma is a rare tumor that accounts for 1-3% of all childhood malignancies. A 16-year-old patient with refractory nasopharyngeal carcinoma, whose treatment has to be interrupted due to COVID-19 positivity.After 6 weeks because of disease progression, we started his chemotherapy altough he is still COVID-19 positive. We didn't see any complication. Prolonged COVID-19 positivity is thought to be associated with the infection of immortal malignant cells located in the nasopharynx Published by Elsevier Editora Ltda. 2021-11 2021-11-07 /pmc/articles/PMC8572567/ http://dx.doi.org/10.1016/j.htct.2021.10.1007 Text en Copyright © 2021 Published by Elsevier Editora Ltda. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle RARE TUMOURS AND HISTIOCYTOSIS
Şahin, Seda
Sarı, Neriman
Özyörük, Derya
Özdemir, Sonay İncesoy
Gülhan, Belgin
İlhan, İnci Ergürhan
PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
title PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
title_full PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
title_fullStr PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
title_full_unstemmed PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
title_short PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
title_sort prolonged covid-19 positivity and chemotherapy in a patient with nasopharengeal carcinoma
topic RARE TUMOURS AND HISTIOCYTOSIS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572567/
http://dx.doi.org/10.1016/j.htct.2021.10.1007
work_keys_str_mv AT sahinseda prolongedcovid19positivityandchemotherapyinapatientwithnasopharengealcarcinoma
AT sarıneriman prolongedcovid19positivityandchemotherapyinapatientwithnasopharengealcarcinoma
AT ozyorukderya prolongedcovid19positivityandchemotherapyinapatientwithnasopharengealcarcinoma
AT ozdemirsonayincesoy prolongedcovid19positivityandchemotherapyinapatientwithnasopharengealcarcinoma
AT gulhanbelgin prolongedcovid19positivityandchemotherapyinapatientwithnasopharengealcarcinoma
AT ilhaninciergurhan prolongedcovid19positivityandchemotherapyinapatientwithnasopharengealcarcinoma

Ejemplares similares